You just read:

Hospira Data on European Biosimilar Epoetin, Retacrit, Affirm Treatment Response, Tolerability in Management of Anemia Secondary to Chemotherapy

News provided by

Hospira, Inc.

03 Jun, 2013, 19:57 BST